Carregant...
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death in a proportion of patients. Among other fact...
Guardat en:
| Publicat a: | Clin Appl Thromb Hemost |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370334/ https://ncbi.nlm.nih.gov/pubmed/32677459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029620938149 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|